These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 31595429)
21. Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson's disease. Fabbri M; Pongmala C; Artusi CA; Romagnolo A; Rizzone MG; Zibetti M; Lopiano L Acta Neurol Scand; 2019 Aug; 140(2):157-161. PubMed ID: 31025312 [TBL] [Abstract][Full Text] [Related]
22. Controlled-release carbidopa/levodopa (CR) in parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations. Deleu D; Jacques M; Michotte Y; Ebinger G Neurology; 1989 Nov; 39(11 Suppl 2):88-92; discussion 95. PubMed ID: 2685654 [TBL] [Abstract][Full Text] [Related]
23. Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease. Fabbri M; Zibetti M; Beccaria L; Merola A; Romagnolo A; Montanaro E; Ferreira JJ; Palermo S; Lopiano L Eur J Neurol; 2019 Mar; 26(3):490-496. PubMed ID: 30347489 [TBL] [Abstract][Full Text] [Related]
24. Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features. Catalán MJ; Escribano PM; Alonso-Frech F Mov Disord; 2017 Apr; 32(4):624-625. PubMed ID: 28116835 [No Abstract] [Full Text] [Related]
25. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649 [TBL] [Abstract][Full Text] [Related]
26. Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease. Willows T; Dizdar N; Nyholm D; Widner H; Grenholm P; Schmiauke U; Urbom A; Groth K; Larsson J; Permert J; Kjellander S J Parkinsons Dis; 2017; 7(4):719-728. PubMed ID: 28984615 [TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson's disease patients. Senek M; Nyholm D; Nielsen EI Eur J Clin Pharmacol; 2018 Oct; 74(10):1299-1307. PubMed ID: 29882153 [TBL] [Abstract][Full Text] [Related]
32. Continuous versus intermittent oral administration of levodopa in Parkinson's disease patients with motor fluctuations: A pharmacokinetics, safety, and efficacy study. Warren Olanow C; Torti M; Kieburtz K; Leinonen M; Vacca L; Grassini P; Heller A; Heller E; Stocchi F Mov Disord; 2019 Mar; 34(3):425-429. PubMed ID: 30653246 [TBL] [Abstract][Full Text] [Related]
33. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease. Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399 [TBL] [Abstract][Full Text] [Related]
34. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes. Antonini A; Yegin A; Preda C; Bergmann L; Poewe W; Parkinsonism Relat Disord; 2015 Mar; 21(3):231-5. PubMed ID: 25585993 [TBL] [Abstract][Full Text] [Related]
35. Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa. Metman LV; Hoff J; Mouradian MM; Chase TN Mov Disord; 1994 Jul; 9(4):463-5. PubMed ID: 7969216 [TBL] [Abstract][Full Text] [Related]
36. [Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease]. Fernandez-Pajarin G; Ares-Pensado B; Sesar A; Iglesias-Canle J; Masa-Vazquez L; Castro A Rev Neurol; 2018 Jul; 67(1):1-5. PubMed ID: 29923594 [TBL] [Abstract][Full Text] [Related]